Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden

Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden

Abstract Objective Convalescent plasma has been tried as therapy for various viral infections. Early observational studies of convalescent plasma treatment for hospitalized COVID-19 patients were promising, but randomized controlled studies were lacking at the time. The objective of this study was t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Karin Holm, Maria N. Lundgren, Jens Kjeldsen-Kragh, Oskar Ljungquist, Blenda Böttiger, Christian Wikén, Jonas Öberg, Nils Fernström, Ebba Rosendal, Anna K. Överby, Julia Wigren Byström, Mattias Forsell, Mona Landin-Olsson, Magnus Rasmussen
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
SARS-CoV2
COVID-19
Convalescent plasma
Oxygen therapy
Desaturation
Medicine
R
Biology (General)
QH301-705.5
Science (General)
Q1-390
Acceso en línea:https://doaj.org/article/b7713b8a6ec64937b394d31d9f097f2f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/b7713b8a6ec64937b394d31d9f097f2f

Ejemplares similares